IJRR

International Journal of Research and Review

| Home | Current Issue | Archive | Instructions to Authors | Journals |

Case Report

Year: 2021 | Month: May | Volume: 8 | Issue: 5 | Pages: 69-72

DOI: https://doi.org/10.52403/ijrr.20210510

Case Report: Post Kala-Azar Dermal Leishmaniasis with History of Visceral Leishmaniasis

Pavankumar Narapaka1, Kalpana Katikala2

1,2M Pharmacy, Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, Export Promotion Industrial Park (EPIP), Zandhaha Road, NH 322,Hajipur, Bihar,844102

Corresponding Author: Pavankumar Narapaka

ABSTRACT

The complication of visceral leishmaniasis is post-kala-azar dermal leishmaniasis (PKDL). PKDL typically occurs as a result of treatment failure or parasite resistance to treatment regimens, as well as poor patient follow-up. In the treatment of visceral leishmaniasis and post-kala-azar dermal leishmaniasis, Liposomal Amphotericin B is considering as first-line therapy. We're going to show you a case where Liposomal Amphotericin B was used to treat it.

Keywords: visceral leishmaniasis, post-kala-azar dermal leishmaniasis, PKDL, kala-azar

[PDF Full Text]